Johnson Pharmacare Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported net loss was INR 0.29 million compared to INR 0.536 million a year ago. Basic loss per share from continuing operations was INR 0.0009 compared to INR 0.0009 a year ago. Diluted loss per share from continuing operations was INR 0.0009 compared to INR 0.0009 a year ago.
For the nine months, sales was INR 32.63 million. Revenue was INR 32.63 million. Net income was INR 4.58 million compared to net loss of INR 1.01 million a year ago. Basic earnings per share from continuing operations was INR 0.0082 compared to basic loss per share from continuing operations of INR 0.0018 a year ago. Diluted earnings per share from continuing operations was INR 0.0082 compared to diluted loss per share from continuing operations of INR 0.0018 a year ago.